Related references
Note: Only part of the references are listed.MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
Yulin Li et al.
CANCER CELL (2014)
The Impact of miRNA-Based Molecular Diagnostics and Treatment of NRF2-Stabilized Tumors
Shinsuke Yamamoto et al.
MOLECULAR CANCER RESEARCH (2014)
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
Suvi-Katri Leivonen et al.
MOLECULAR ONCOLOGY (2014)
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Corine M. Beaufort et al.
PLOS ONE (2014)
RSK Isoforms in Cancer Cell Invasion and Metastasis
Florian J. Sulzmaier et al.
CANCER RESEARCH (2013)
Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
Antonia L. Pritchard et al.
CLINICAL CANCER RESEARCH (2013)
The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin
Marijn T. M. van Jaarsveld et al.
EUROPEAN JOURNAL OF CANCER (2013)
Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment
Doris Bach et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2013)
RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
H. Ray-David et al.
ONCOGENE (2013)
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
M. T. M. van Jaarsveld et al.
ONCOGENE (2013)
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
Y-N Liu et al.
ONCOGENE (2013)
Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11
Chen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Regulation and function of the RSK family of protein kinases
Yves Romeo et al.
BIOCHEMICAL JOURNAL (2012)
The Changing View of High-Grade Serous Ovarian Cancer
Els M. J. J. Berns et al.
CANCER RESEARCH (2012)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance
W. Li et al.
ONCOGENE (2012)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity
Stacia K. Wyman et al.
GENOME RESEARCH (2011)
Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
Jonathan A. Ledermann et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Deep sequencing of microRNA precursors reveals extensive 3′ end modification
Martin A. Newman et al.
RNA (2011)
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
H. Burger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
Sebastien Cagnol et al.
FEBS JOURNAL (2010)
MicroRNAs in ovarian cancer biology and therapy resistance
Marijn T. M. van Jaarsveld et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas A Clinicopathologic and Molecular Genetic Analysis
Ayse Ayhan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Epithelial ovarian cancer Focus on genetics and animal models
Weiwei Shan et al.
CELL CYCLE (2009)
βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis
Elinor Dehan et al.
MOLECULAR CELL (2009)
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
J. Rainer et al.
LEUKEMIA (2009)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Bim and the pro-survival bcl-2 proteins - Opposites attract, ERK repels
Katherine E. Ewings et al.
CELL CYCLE (2007)
ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL
Katherine E. Ewings et al.
EMBO JOURNAL (2007)
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance
Anamaria Brozovic et al.
CANCER LETTERS (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Yong Sun Lee et al.
GENES & DEVELOPMENT (2007)
The colorectal microRNAome
JM Cummins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients
Trevor G. Shepherd et al.
NATURE PROTOCOLS (2006)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Mitogen-activated protein kinases in cell-cycle control
RA MacCorkle et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2005)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
